Free Trial

IperionX Limited Sponsored ADR (IPX) - What Are Researchers Thinking About This Stock?

IperionX logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst sentiment is moderately bullish: Six of seven analysts rate IperionX a buy, while one recommends selling. The average 12-month price target is $42, well above the stock’s recent $15.62 price.
  • IPX shares have declined sharply: The stock is near its 12-month low of $15.05 versus a high of $61.45, with 50-day and 200-day moving averages of $20.66 and $27.27, respectively. B. Riley also cut its price target from $52 to $34 while maintaining a buy rating.
  • IperionX is developing a domestic, lower-carbon titanium supply chain: Its Tennessee Titan Project and proprietary hydrogen-assisted processing technology are aimed at supplying titanium products for aerospace, defense, automotive, medical and other advanced manufacturing markets.
  • Five stocks to consider instead of IperionX.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $42.00.

IPX has been the subject of several research analyst reports. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of IperionX in a research note on Friday, July 17th. B. Riley Financial dropped their price objective on IperionX from $52.00 to $34.00 and set a "buy" rating on the stock in a research note on Wednesday, September 30th. Roth Capital set a $53.00 price objective on IperionX in a report on Wednesday, August 5th. Finally, Jefferies Financial Group started coverage on IperionX in a report on Wednesday, September 2nd. They issued a "buy" rating and a $26.00 target price for the company.

Check Out Our Latest Research Report on IPX

Institutional Trading of IperionX

Several institutional investors and hedge funds have recently made changes to their positions in IPX. Private Advisor Group LLC grew its holdings in IperionX by 69.9% during the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock worth $1,643,000 after acquiring an additional 25,964 shares in the last quarter. Corigliano Investment Advisers LLC bought a new stake in shares of IperionX in the 4th quarter valued at about $362,000. DLD Asset Management LP bought a new stake in shares of IperionX in the 1st quarter valued at about $260,000. Connective Capital Management LLC bought a new stake in shares of IperionX in the 2nd quarter valued at about $160,000. Finally, GAMMA Investing LLC lifted its position in shares of IperionX by 40.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company's stock worth $50,000 after purchasing an additional 483 shares during the period. 2.76% of the stock is currently owned by institutional investors.

IperionX Stock Performance

IPX stock opened at $15.62 on Tuesday. IperionX has a 12 month low of $15.05 and a 12 month high of $61.45. The firm's 50-day moving average is $20.66 and its 200 day moving average is $27.27. The company has a quick ratio of 2.95, a current ratio of 3.24 and a debt-to-equity ratio of 0.04.

IperionX (NASDAQ:IPX - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported ($0.50) earnings per share (EPS) for the quarter. On average, analysts anticipate that IperionX will post -0.13 earnings per share for the current fiscal year.

About IperionX

(Get Free Report)

IperionX Limited NASDAQ: IPX is a materials technology company focused on developing a U.S.-based, lower-carbon titanium supply chain. The company is working to produce titanium metal, powder and other titanium products for aerospace, defense, automotive, medical and other advanced manufacturing applications.

IperionX is developing its Titan Project in Tennessee, which is designed to supply titanium minerals and support domestic production of titanium products. The project is intended to integrate the processing of titanium mineral resources with downstream manufacturing, reducing reliance on overseas sources of titanium.

The company is also advancing proprietary processing technologies, including its Hydrogen Assisted Metallothermic Reduction process, which is designed to produce titanium metal and powder with lower energy requirements than conventional methods.

Further Reading

Analyst Recommendations for IperionX (NASDAQ:IPX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IperionX Right Now?

Before you consider IperionX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.

While IperionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines